 Genetic Engineering News |
SkyePharma falls as Abbott gets shot of asthma drug
This is London Drugmaker SkyePharma today saw its shares plunge 5% after pharmaceuticals giant Abbott Laboratories ended the deal to sell its asthma drug Flutiform in … SkyePharma loses US partner Abbott bows out of Flutiform pact Abbott Returns US Flutiform Rights to SkyePharma after Negative FDA Feedback |
View full post on asthma – Google News